Goldman Sachs:
- Reiterated Outperform on FSH, YUM, PFE and BBBY.
- Rated AIG Outperform.
Smith Barney:
- Said to Sell ATK, target $60, and Buy DRS, target .
- Reiterated Buy on CD, target $28.
- Reiterated Buy on AA, target $42.
- Reiterated Buy on FCX, target $50.
- Raised TPP to Buy, target $43.
CSFB:
- Raised OTEX to Outperform, target $25.
Prudential:
- Downgraded LTD to Underweight, target $21.
- Reiterated Buy on ROK, target $70.
Merrill Lynch:
- Rated NOV Buy, target $55.
- Reiterated Buy on CELG, target $42.
Banc of America:
- Reiterated Buy on LYO, target $35.
Jeffries:
- Rated OSUR Buy, target $11.
Wachovia:
- Rated ISIL, LLTC and MCRL Outperform.
CIBC:
- Rated CVH Sector Outperform, target $84.
- Rated CI Sector Outperform, target $110.
- Rated WLP Sector Outperform, target $150.
- Rated UNH Sector Outperform, target $112.
- Rated AET Sector Outperform, target $88.
- Rated MGLN Sector Underperform, target $30.
- Rated HNT Sector Underperform, target $34.
UBS:
- Raised HBAN to Buy, target $27.
Oppenheimer:
- Raised HCA to Buy, target $62.
- Raised CMVT to Buy, target $30.
Piper Jaffray:
- Raised SUPX to Outperform, target $23.
- Rated WOOF Outperform, target $24.
- Rated CENT Outperform, target $50.
Legg Mason:
- Rated AMAT Buy, target $24.
- Rated CYMI Buy, target $34.
- Rated KLAC Buy, target $59.
- Rated LRCX Buy, target $45.
- Rated MTSN Buy, target $15.
- Rated VSEA Buy, target $50.
No comments:
Post a Comment